China Shenghuo Pharmaceutical Holdings

China Shenghuo Pharmaceutical Holdings is a pharmaceutical company primarily focused on the development and manufacture of Traditional Chinese Medicine (TCM) for cardiovascular and cerebrovascular health. Based in Kunming, China, the company is best known for its flagship product, Xuesaitong Soft Capsules, which utilizes saponins extracted from Panax notoginseng (Sanchi). The company operates through its main subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., and maintains a significant presence in the Chinese herbal medicine market. In 2016, the company was acquired by China Resources Sanjiu Medical & Pharmaceutical, a leading state-owned pharmaceutical group in China. Following the acquisition, it continues to operate as a key production base for Sanchi-based medicinal products.